Remove Magazine Remove Pharma Remove Specialization
article thumbnail

Wego health’s self-serving survey

World of DTC Marketing

SUMMARY: Patient influencers trust social media groups more than pharma websites for health information, according to a survey from Wego Health. Imagine a survey like this from a company that specializes in patient influencers. Only 3% said they prefer pharma websites” The key here is the term “influencers.”

Media 180
article thumbnail

Time to rethink the objective of DTC marketing

World of DTC Marketing

The last Prevention Magazine study indicated that 7% of DTC TV ads effectively drove patients to ask for/about a medication. NOBODY goes to a pharma website and says “I’m going to ask for that drug!” Pharma websites need to evolve. Targeted in the right publications, print ads can be a great DTC marketing tool.

Marketing 155
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PUBLISHER’S MESSAGE: The Golden Age of Innovation

PM360

We’re featuring AI in this month’s issue as the topic can’t be ignored—generative AI is creating huge waves in the Pharma industry and it’s all we’re talking about. There are ethical considerations around AI in Pharma, from protecting intellectual property, to providing accurate information, to programming bias, to name a few.

Ethics 52
article thumbnail

Collaboration & Agility – Core Themes & Lessons from Reuters Pharma USA 2021

Pharma Marketing Network

At this year’s Pharma USA conference, C ollaboration was the theme of the opening keynote session and a common thread woven throughout the event as industry leaders gathered to discuss how to move “Beyond Normal” to shape the future of health. Collaboration in Action. Build & Scale. Keeping Patients at the Center of Care.

Pharma 59
article thumbnail

Bob Harrell

Pharma Marketing Network

Partner at Rebound Communications, a firm that specializes in Commercial Acceleration for tech and data companies in life sciences and healthcare. Rebound was recently recognized by Inc Magazine as one of America’s 5000 fastest-growing private companies, coming in at #702 on the list with 893% growth over the past three years.

article thumbnail

For rare disease patients in Mainland China, hope of greater access to treatment

Clarivate

Multinational pharmas seek entry for their products. Multinational pharmas have taken notice of the recent policy focus of Mainland China’s healthcare authorities on rare diseases. China’s rapidly evolving and increasingly dynamic rare disease market provides pharmas an opportunity for strong growth. The Lancet. 2019; 2:8-15. (in

article thumbnail

PM360 Announces 2023 Trailblazer Award Finalists

PM360

Bigfoot Biomedical Ethicon, a Johnson & Johnson MedTech Company Medtronic Zimmer Biomet COMPANY OF THE YEAR: SPECIALTY PHARMA/BIOTECH argenx Chiesi GRD Cullinan Oncology, Inc. Brett Sarnoff, Vice President of Marketing Medical Device & Pharma Systems, North America, B. Braun Medical, Inc. Braun Medical, Inc. Tolstrup, Sr.